Essentialis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
Phase 2
- Conditions
- Prader-Willi Syndrome
- Interventions
- First Posted Date
- 2016-09-08
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02893618
Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
- First Posted Date
- 2014-01-13
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT02034071
- Locations
- 🇺🇸
University of California, Irvine, Orange, California, United States
Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects
Phase 1
Completed
- Conditions
- Hypertriglyceridmia
- Interventions
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT01211860
- Locations
- 🇺🇸
Cetero, Fargo, North Dakota, United States
Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia
Phase 2
Completed
- Conditions
- HypertriglyceridemiaDyslipidemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-09-30
- Last Posted Date
- 2014-01-10
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT01211847
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Phase 3
Withdrawn
- Conditions
- Hypertriglyceridemia
- Interventions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Essentialis, Inc.
- Registration Number
- NCT00973271
Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
Phase 1
Withdrawn
- Conditions
- Hypertriglyceridemia
- Interventions
- First Posted Date
- 2009-05-14
- Last Posted Date
- 2016-09-01
- Lead Sponsor
- Essentialis, Inc.
- Registration Number
- NCT00901823
Diazoxide Choline in Hypertriglyceridemia
- First Posted Date
- 2008-06-12
- Last Posted Date
- 2010-11-07
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00696475
- Locations
- 🇺🇸
Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Allied Research International/Cetero Research, Miami Gardens, Florida, United States
🇺🇸National Research Institute, Los Angeles, California, United States
Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations
- First Posted Date
- 2008-06-03
- Last Posted Date
- 2010-11-07
- Lead Sponsor
- Essentialis, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT00688857
- Locations
- 🇺🇸
PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States
© Copyright 2025. All Rights Reserved by MedPath